| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 33.75▲ | 33.36▲ | 33.14▲ | 38.81▼ | 37.33▼ |
| MA10 | 33.35▲ | 33.21▲ | 35.56▼ | 38.77▼ | 35.27▼ |
| MA20 | 33.24▲ | 35.94▼ | 37.87▼ | 38.30▼ | 35.57▼ |
| MA50 | 33.19▲ | 38.39▼ | 38.83▼ | 35.16▼ | 38.96▼ |
| MA100 | 36.40▼ | 38.73▼ | 38.52▼ | 36.36▼ | 45.70▼ |
| MA200 | 38.09▼ | 38.16▼ | 36.78▼ | 37.78▼ | 44.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.156▲ | -0.096▼ | -0.687▼ | -0.346▼ | 0.637▲ |
| RSI | 63.072▲ | 33.233▼ | 27.780▼ | 33.219▼ | 42.972▼ |
| STOCH | 95.014▲ | 40.842 | 10.393▼ | 75.300 | 84.018▲ |
| WILL %R | 0.000▲ | -79.665▼ | -79.677▼ | -79.739▼ | -60.493 |
| CCI | 138.622▲ | -17.510 | -63.544 | -320.143▼ | 34.257 |
| ▼ BREAK | $ANIK Price Breaks 10 Days Low | Set Alert |
| ▼ BREAK | $ANIK Price Breaks 20 Days Low | Set Alert |
| ▼ GAP | $ANIK Open Gap Down %2 | Set Alert |
| ▼ GAP | $ANIK Open Gap Down %3 | Set Alert |
| ▼ GAP | $ANIK Open Gap Down %5 | Set Alert |
| MA | $ANIK Price Crossed Below MA(7) | Set Alert |
| MA | $ANIK Price Crossed Below MA(13) | Set Alert |
| MA | $ANIK Price Crossed Below MA(26) | Set Alert |
| MA | $ANIK Price Crossed Below MA(50) | Set Alert |
| MA | $ANIK Price Crossed Below MA(200) | Set Alert |
| ▼ MACD | $ANIK MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| RSI | $ANIK RSI(14) Crossed Below 50 | Set Alert |
| ▼ RSI | $ANIK RSI(14) Crossed Below 70 | Set Alert |
|
Friday, February 22, 2019 05:21 AM
Today, Anika Therapeutics Inc (NASDAQ:ANIK) stock was downgraded by First Analysis from Outperform to Neutral with a price target of $37.00. There are 1 Hold Ratings, 1 Buy Ratings, no Strong Buy ...
|
|
Thursday, February 21, 2019 04:45 PM
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary ...
|
|
Thursday, February 21, 2019 01:59 PM
Anika Therapeutics (NASDAQ:ANIK) Q4 results ($M): Revenue: 27.0 (-8.2%); product sales: 27.0 (-6.6%). Net income: 7.7 (-4.9%); EPS: 0.54 (+1.9%). 2019 guidance: Revenue growth: 3 - 6%; net income ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/02/19 | 35.645 | 36.50 | 32.27 | 33.98 | 468,032 |
| 21/02/19 | 40.03 | 40.71 | 39.725 | 40.49 | 128,706 |
| 20/02/19 | 39.65 | 40.18 | 39.32 | 40.05 | 100,895 |
| 19/02/19 | 39.33 | 40.23 | 39.31 | 40.00 | 105,477 |
| 15/02/19 | 39.22 | 39.98 | 39.13 | 39.52 | 85,581 |
| 14/02/19 | 38.78 | 39.58 | 38.78 | 39.07 | 82,942 |
| 13/02/19 | 39.21 | 39.63 | 38.865 | 38.93 | 209,198 |
| 12/02/19 | 38.58 | 39.26 | 38.47 | 39.14 | 64,222 |
| 11/02/19 | 38.25 | 38.61 | 38.07 | 38.32 | 79,142 |
| 08/02/19 | 38.10 | 38.41 | 37.7577 | 38.19 | 87,710 |
|
|
||||
|
|
||||
|
|
||||
|
|